(E)-N-(6-morpholinobenzo[d]thiazol-2-yl)-2-(4-(2,4-dichlorobenzyloxy)-2-hydroxybenzylidene)hydrazinecarboxamide

ID: ALA3357974

PubChem CID: 137007048

Max Phase: Preclinical

Molecular Formula: C26H23Cl2N5O4S

Molecular Weight: 572.47

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(N/N=C/c1ccc(OCc2ccc(Cl)cc2Cl)cc1O)Nc1nc2ccc(N3CCOCC3)cc2s1

Standard InChI:  InChI=1S/C26H23Cl2N5O4S/c27-18-3-1-17(21(28)11-18)15-37-20-5-2-16(23(34)13-20)14-29-32-25(35)31-26-30-22-6-4-19(12-24(22)38-26)33-7-9-36-10-8-33/h1-6,11-14,34H,7-10,15H2,(H2,30,31,32,35)/b29-14+

Standard InChI Key:  HMZPPGUUXBTWMR-IPPBACCNSA-N

Molfile:  

     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   18.3223  -11.7768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0190  -11.3589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3327  -12.5969    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7532  -12.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0482  -12.9936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7345  -11.7555    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8193   -6.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1666  -10.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6406  -10.2633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6484  -11.5955    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   27.5993   -7.3637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3498  -10.2109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1547  -11.7520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9373   -9.5071    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.4402   -5.2237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8649  -11.3433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9457  -10.9195    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5613   -8.0874    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.3780   -8.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0371   -5.9361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4451  -10.5241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2224   -5.9394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1289  -10.9244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7916   -8.7839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1528  -10.1156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7783   -7.3712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0120   -8.0684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0266   -4.5195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2056   -4.5282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4440  -11.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8062   -5.2370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3875   -9.4925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0025   -6.6545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6078   -8.7804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5707   -9.4974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.8600  -10.5205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4502   -6.6413    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   30.4288   -3.8081    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  6  4  1  0
  5  4  1  0
  1  3  1  0
  2  1  1  0
  6  2  1  0
  3  5  1  0
 29 31  2  0
 23 17  1  0
 35 32  2  0
 19 18  1  0
 33  7  1  0
 13 16  2  0
 17 12  1  0
 12  8  1  0
  7 22  1  0
 23  9  2  0
 21 30  2  0
 11 33  1  0
 12 14  2  0
 16 10  1  0
 15 28  2  0
 20 15  1  0
  9 36  1  0
 27 11  2  0
 30 13  1  0
  8 35  1  0
 22 20  2  0
 25 21  1  0
 36 16  1  0
 10 23  1  0
 34 27  1  0
 19 24  1  0
 32 24  1  0
 24 34  2  0
 31 22  1  0
 28 29  1  0
 11 26  1  0
 36 25  2  0
 26 19  2  0
 30  6  1  0
 20 37  1  0
 28 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3357974

    ---

Associated Targets(Human)

NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-N-SH (1499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 572.47Molecular Weight (Monoisotopic): 571.0848AlogP: 5.88#Rotatable Bonds: 7
Polar Surface Area: 108.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.42CX Basic pKa: 0.61CX LogP: 6.20CX LogD: 5.92
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.19Np Likeness Score: -2.11

References

1. Ma J, Chen D, Lu K, Wang L, Han X, Zhao Y, Gong P..  (2014)  Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.,  86  [PMID:25171780] [10.1016/j.ejmech.2014.08.058]

Source